ResearchAndMarkets.com released a comprehensive report covering over 1,859 clinical-stage partnering deals in pharmaceuticals and biotechnology from 2020 to 2026. The report includes detailed financial terms such as upfront payments, milestones, and royalties, along with direct access to contract documents filed with the SEC. It offers valuable insights into deal structures, negotiation strategies, and key industry players, helping companies benchmark and optimize their clinical-stage partnerships. This resource is essential for professionals involved in biopharma dealmaking to understand market trends and improve negotiation outcomes.
Goodfirms has introduced the Prediction Marketplace Platform Vendor Recipe, a comprehensive guide that maps over 100 verified vendors across 20 technology categories and four build phases, with costs ranging from $25,000 to over $2 million. This reso...
The global mass spectrometry market, valued at $6.68 billion in 2025, is projected to grow to $14.09 billion by 2035 at a CAGR of 7.74%. Growth is fueled by increased adoption in pharmaceutical manufacturing, biotechnology research, clinical diagnost...
The global cancer biomarkers market is projected to grow from $28.25 billion in 2026 to $54.48 billion by 2032, at an 11.6% CAGR. Growth is fueled by rising cancer rates, technological advances like multi-omics and AI integration, and increased deman...
Datadog CEO Olivier Pomel has sold 127,000 shares of the company, generating $32.9 million from the sale. This move may indicate personal financial planning or portfolio diversification by the CEO. Investors might watch for any further insider sales ...
Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed client-serving trades involving 21,254 ordinary shares bought and sold on July 16, 2026. The transactions occurred at prices between 936 and 948 currency units per shar...
